Back to Atlas
APotentially durableStandard research/education caution
CMP-0058
Research tool
Geldanamycin
Senolytic / HSP90
Research HSP90 senolytic scaffold
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Natural-product small molecule
- Primary mechanism
- HSP90 inhibition
- Primary market use
- Senolytic research
Pharmacology
- Molecular weight (Da)
- 560.64
- Oral bioavailability
- N/A; not suitable as oral consumer compound
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Research tool
- Value-for-money score
- 1 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Parent HSP90 inhibitor with toxicity; mainly a research scaffold